Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios

Radiology

Volumn 202, Issue 3, 1997, Pages 739-744

  Ma, Loralie D ^a   Frassica, Frank J ^b   McCarthy, Edward F ^a   Bluemke, David A ^a   Zerhouni, Elias A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone neoplasms, diagnosis; Chondromyxoid fibroma; Gadolinium; Muscles, neoplasms; Myoma; Soft tissues, neoplasms

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE PROCESSING; IMAGE QUALITY; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; TUMOR LOCALIZATION;

EID: 0031049853     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.3.9051028     Document Type: Article

References (16)

1. Bloem JL, Reiser MF, Vanel D. Magnetic resonance contrast agents in the evaluation of the musculoskeletal system. Magn Reson Q 1990; 6:136-163.
2. Erlemann R, Reiser MF, Peters PE, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171:767-773.
3. Verstraete KL, De Deene Y, Roels H, et al. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging - parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
4. Erlemann R, Sciuk J, Bosse A, et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 1990; 175:791-796.
5. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992; 184:243-248.
6. Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol 1992; 27:367-373.
7. Hanna SL, Reddick WE, Parham DM, Gronemeyer S, Taylor JS, Fletcher BD. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results. JMRI 1993; 3:849-853.
8. Reddick WE, Langston JW, Meyer WH, et al. Discrete signal processing of dynamic contrast-enhanced MR imaging: statistical validation and preliminary clinical application. JMRI 1994; 4:397-404.
9. Van der Woude HJ, Bloem JL, Verstraete K, et al. Osteosarcoma and Ewings sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR 1995; 165:593-598.
10. De Baere T, Vanel D, Shapeero L, et al. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185: 587-592.
11. Vanel D, Tardivon A, Shapeero LG, et al. Dynamic contrast-enhanced subtraction MR imaging in follow-up of aggressive soft-tissue tumors: a prospective study of 74 patients (abstr). Radiology 1993; 189(P):205.
12. Verstraete KL, Van der Woude HJ, Hogendoorn PCW, De Deene Y, Kunnen M, Bloem JL. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications JMRI 1996; 6:311-321.
13. Lang P, Honda G, Roberts T, et al. Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR imaging with spatial mapping of instantaneous enhancement rates. Radiology 1995; 197:831-839.
14. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47:3038-3050.
15. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641-2658.
16. Jain RK. Barriers to drug delivery in solid tumors. Sci Am, July 1994; 58-65.